Veeva Systems Inc. (VEEV) Analysts See $0.23 EPS

May 23, 2018 - By Louis Casey

Veeva Systems Inc. (NYSE:VEEV) LogoInvestors sentiment decreased to 1.06 in Q4 2017. Its down 0.57, from 1.63 in 2017Q3. It is negative, as 51 investors sold Veeva Systems Inc. shares while 91 reduced holdings. 54 funds opened positions while 96 raised stakes. 98.12 million shares or 2.33% more from 95.88 million shares in 2017Q3 were reported.
Cambridge Investment Research Advsr accumulated 38,760 shares. 4,432 are owned by Bell Financial Bank. Evercore Wealth Mngmt Lc invested 0% in Veeva Systems Inc. (NYSE:VEEV). Gilder Gagnon Howe And Commerce Ltd Liability stated it has 0.26% in Veeva Systems Inc. (NYSE:VEEV). Prelude Mgmt Ltd Limited Liability Company accumulated 13,062 shares. Apg Asset Nv holds 0% or 37,100 shares in its portfolio. Teacher Retirement Of Texas holds 106,543 shares or 0.04% of its portfolio. Tci Wealth Advsrs accumulated 53 shares or 0% of the stock. Connecticut-based Cubist Systematic Strategies Limited Liability Company has invested 0.02% in Veeva Systems Inc. (NYSE:VEEV). First Republic Investment Management stated it has 0.01% of its portfolio in Veeva Systems Inc. (NYSE:VEEV). Parkside Bancorporation & reported 1,583 shares stake. Barbara Oil Co has 10,000 shares for 0.35% of their portfolio. Pittenger And Anderson owns 0% invested in Veeva Systems Inc. (NYSE:VEEV) for 30 shares. Thrivent Financial For Lutherans has invested 0.04% in Veeva Systems Inc. (NYSE:VEEV). Perigon Wealth Mngmt Ltd Liability accumulated 0.41% or 20,000 shares.

Since December 15, 2017, it had 0 insider purchases, and 23 sales for $20.51 million activity. $83,610 worth of stock was sold by SEKHRI PAUL J on Wednesday, March 21. Shares for $206,202 were sold by Lequient Frederic on Thursday, March 1. Wallach Matthew J also sold $927,409 worth of Veeva Systems Inc. (NYSE:VEEV) on Thursday, March 15. Faddis Jonathan had sold 2,462 shares worth $186,571. The insider MATEO ALAN sold 340 shares worth $23,613. Cabral Timothy S sold 50,000 shares worth $2.79 million.

Analysts expect Veeva Systems Inc. (NYSE:VEEV) to report $0.23 EPS on May, 24 after the close.They anticipate $0.09 EPS change or 64.29 % from last quarter’s $0.14 EPS. VEEV’s profit would be $32.93 million giving it 81.97 P/E if the $0.23 EPS is correct. After having $0.17 EPS previously, Veeva Systems Inc.’s analysts see 35.29 % EPS growth. The stock decreased 1.49% or $1.14 during the last trading session, reaching $75.41. About 861,134 shares traded. Veeva Systems Inc. (NYSE:VEEV) has risen 42.88% since May 23, 2017 and is uptrending. It has outperformed by 31.33% the S&P500.

Veeva Systems Inc. (NYSE:VEEV) Ratings Coverage

Among 9 analysts covering Veeva Systems (NYSE:VEEV), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Veeva Systems had 12 analyst reports since December 5, 2017 according to SRatingsIntel. The company was maintained on Thursday, March 1 by Morgan Stanley. Morgan Stanley upgraded the stock to “Overweight” rating in Tuesday, January 30 report. As per Wednesday, February 28, the company rating was maintained by Canaccord Genuity. The company was downgraded on Friday, March 9 by J.P. Morgan. The firm has “Hold” rating by Raymond James given on Tuesday, December 5. The company was maintained on Friday, March 2 by KeyBanc Capital Markets. The firm earned “Neutral” rating on Friday, March 9 by JP Morgan. Canaccord Genuity maintained the shares of VEEV in report on Friday, April 13 with “Buy” rating. Stifel Nicolaus maintained the shares of VEEV in report on Wednesday, February 28 with “Buy” rating. The company was maintained on Wednesday, December 6 by Canaccord Genuity.

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The company has market cap of $10.80 billion. The firm offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, which allow pharmaceutical and biotechnology companies to target and support sales and marketing to physicians, other healthcare professionals, and healthcare organizations through various touch points, including in-person, email, and online; and Veeva Vault, a cloud enterprise content management platform and suite of applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, and quality. It has a 81.97 P/E ratio. It also provides Veeva Network master data management solutions for the management of customer master and product master data.

Veeva Systems Inc. (NYSE:VEEV) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.